HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Control of carcinoid syndrome with everolimus.

AuthorsJ Capdevila, I Díez Miranda, G Obiols, J Tabernero
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 22 Issue 1 Pg. 237-239 (Jan 2011) ISSN: 1569-8041 [Electronic] England
PMID21169474 (Publication Type: Case Reports, Letter)
Chemical References
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Everolimus
  • Octreotide
  • Sirolimus
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carcinoma, Neuroendocrine (drug therapy)
  • Everolimus
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha (administration & dosage)
  • Malignant Carcinoid Syndrome (drug therapy)
  • Middle Aged
  • Octreotide (administration & dosage)
  • Recombinant Proteins
  • Sirolimus (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: